Steroidogenic acute regulatory protein-related lipid transfer (START) proteins in non-vesicular cholesterol transport

Cholesterol Transporters of the START Domain Protein Family in Health and Disease: START Proteins-Structure and Function

Volumn 9781493911127, Issue , 2014, Pages 173-188

  Iaea, David B ^a   Mao, Shu ^a   Maxfield, Frederick R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cholesterol; Homeostasis; Lipid; Non vesicular; STARD4; STARD5; START

Indexed keywords

EID: 84930033659     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1112-7_8     Document Type: Chapter

References (87)

1. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev. 1997;77(3):759-803.
2. Myers JN, Tabas I, Jones NL, Maxfield FR. Beta-very low density lipoprotein is sequestered in surface-connected tubules in mouse peritoneal macrophages. J Cell Biol. 1993;123(6 Pt 1):1389-402.
3. Skiba PJ, Zha X, Maxfield FR, Schissel SL, Tabas I. The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent. J Biol Chem. 1996;271(23):13392-400.
4. McIntosh AL, Atshaves BP, Huang H, Gallegos AM, Kier AB, Schroeder F. Fluorescence techniques using dehydroergosterol to study cholesterol trafficking. Lipids. 2008;43(12):1185-208.
5. Schroeder F, Barenholz Y, Gratton E, Thompson TE. A fluorescence study of dehydroergosterol in phosphatidylcholine bilayer vesicles. Biochemistry. 1987;26(9):2441-8.
6. Hao M, Lin SX, Karylowski OJ, Wustner D, McGraw TE, Maxfield FR. Vesicular and nonvesicular sterol transport in living cells. The endocytic recycling compartment is a major sterol storage organelle. J Biol Chem. 2002;277(1):609-17.
7. Mesmin B, Pipalia NH, Lund FW, Ramlall TF, Sokolov A, Eliezer D, et al. STARD4 abundance regulates sterol transport and sensing. Mol Biol Cell. 2011;22(21):4004-15.
8. Garbarino J, Pan M, Chin HF, Lund FW, Maxfield FR, Breslow JL. STARD4 knockdown in HepG2 cells disrupts cholesterol trafficking associated with the plasma membrane, ER, and ERC. J Lipid Res. 2012;53(12):2716-25.
9. van Meer G. Cellular lipidomics. EMBO J. 2005;24(18):3159-65.
10. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125-38.
11. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 2008;8(6):512-21.
12. Maxfield FR, Menon AK. Intracellular sterol transport and distribution. Curr Opin Cell Biol. 2006;18(4):379-85.
13. Blanchette-Mackie EJ, Pentchev P. Cholesterol distribution in Golgi, lysosomes and endoplasmic reticulum. In: Chang TY, Freeman D, editors. Intracellular cholesterol trafficking. US: Springer; 1998. S. 53-73.
14. Mobius W, van Donselaar E, Ohno-Iwashita Y, Shimada Y, Heijnen HFG, Slot JW, et al. Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic. 2003;4(4):222-31.
15. Liscum L, Munn NJ. Intracellular cholesterol transport. Biochim Biophys Acta. 1999;1438(1):19-37.
16. Huang J, Feigenson GW. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys J. 1999;76(4):2142-57.
17. Pani B, Ong HL, Liu X, Rauser K, Ambudkar IS, Singh BB. Lipid rafts determine clustering of STIM1 in endoplasmic reticulum-plasma membrane junctions and regulation of storeoperated Ca2+ entry (SOCE). J Biol Chem. 2008;283(25):17333-40.
18. Galan C, Woodard GE, Dionisio N, Salido GM, Rosado JA. Lipid rafts modulate the activation but not the maintenance of store-operated Ca (2+) entry. Biochim Biophys Acta. 2010;1803(9):1083-93.
19. Das A, Goldstein JL, Anderson DD, Brown MS, Radhakrishnan A. Use of mutant 125I-Perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells. Proc Natl Acad Sci U S A. 2013;110(26):10580-5.
20. Rosenbaum AI, Maxfield FR. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J Neurochem. 2011;116(5):789-95.
21. Siperstein MD, Fagan VM. Deletion of the cholesterol-negative feedback system in liver tumors. Cancer Res. 1964;24:1108-15.
22. Tabas I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ. 2004;11(Suppl 1):2-6.
23. Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124(1):35-46.
24. Brown MS, Goldstein JL. Cholesterol feedback: from Schoenheimer's bottle to Scap's ME-LADL. J Lipid Res. 2009;50(Suppl):5-27.
25. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A. 2003;100(21):12027-32.
26. Wustner D, Mondal M, Tabas I, Maxfield FR. Direct observation of rapid internalization and intracellular transport of sterol by macrophage foam cells. Traffic. 2005;6(5):396-412.
27. Mesmin B, Maxfield FR. Intracellular sterol dynamics. Biochim Biophys Acta. 2009;1791(7):636-45.
28. Li X, Rivas MP, Fang M, Marchena J, Mehrotra B, Chaudhary A, et al. Analysis of oxysterol binding protein homologue Kes1p function in regulation of Sec14p-dependent protein transport from the yeast golgi complex. J Cell Biol. 2002;157(1):63-77.
29. Maxfield FR, van Meer G. Cholesterol, the central lipid of mammalian cells. Curr Opin Cell Biol. 2010;22(4):422-9.
30. Urbani L, Simoni RD. Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane. J Biol Chem. 1990;265(4):1919-23.
31. Baumann NA, Sullivan DP, Ohvo-Rekila H, Simonot C, Pottekat A, Klaassen Z, et al. Transport of newly synthesized sterol to the sterol-enriched plasma membrane occurs via nonvesicular equilibration. Biochemistry. 2005;44(15):5816-26.
32. Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol. 2009;29(4):431-8.
33. Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol. 2004;5(2):121-32.
34. D'Angelo G, Vicinanza M, De Matteis MA. Lipid-transfer proteins in biosynthetic pathways. Curr Opin Cell Biol. 2008;20(4):360-70.
35. Mesmin B, Antonny B, Drin G. Insights into the mechanisms of sterol transport between organelles. Cell Mol Life Sci. 2013 Sept; 70(18):3405-21.
36. Clark BJ. The mammalian START domain protein family in lipid transport in health and disease. J Endocrinol. 2012;212(3):257-75.
37. Prinz WA. Non-vesicular sterol transport in cells. Prog Lipid Res. 2007;46(6):297-314.
38. Beh CT, McMaster CR, Kozminski KG, Menon AK. A detour for yeast oxysterol binding proteins. J Biol Chem. 2012;287(14):11481-8.
39. Tsujishita Y, Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol. 2000;7(5):408-14.
40. Iyer LM, Koonin E V, Aravind L. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins-Struct Funct Genet. 2001;43(2):134-44.
41. Ponting CP, Aravind L. START: a lipid binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem Sci. 1999;24(4):130-2.
42. Soccio RE, Breslow JL. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J Biol Chem. 2003;278(25):22183-6.
43. Romanowski MJ, Soccio RE, Breslow JL, Burley SK. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc Natl Acad Sci U S A. 2002;99(10):6949-54.
44. Lavigne P, Najmanivich R, Lehoux JG. Mammalian StAR-related lipid transfer (START) domains with specificity for cholesterol: structural conservation and mechanism of reversible binding. Sub-cell Biochem. 2010;51:425-37.
45. Murcia M, Faraldo-Gomez JD, Maxfield FR, Roux B. Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol. J Lipid Res. 2006;47(12):2614-30.
46. Bose HS, Whittal RM, Baldwin MA, Miller WL. The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule. Proc Natl Acad Sci U S A. 1999;96(13):7250-5.
47. Friedland N, Liou HL, Lobel P, Stock AM. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc Natl Acad Sci U S A. 2003;100(5):2512-7.
48. Im YJ, Raychaudhuri S, Prinz WA, Hurley JH. Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature. 2005;437(7055):154-8.
49. Roderick SL, Chan WW, Agate DS, Olsen LR, Vetting MW, Rajashankar KR, et al. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat Struct Biol. 2002;9(7):507-11.
50. Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakatsuki S, Nishijima M, et al. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A. 2008;105(2):488-93.
51. Soccio RE, Adams RM, Romanowski MJ, Sehayek E, Burley SK, Breslow JL. The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc Natl Acad Sci U S A. 2002;99(10):6943-8.
52. Rodriguez-Agudo D, Calderon-Dominguez M, Ren S, Marques D, Redford K, Medina-Torres MA, et al. Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts. Biochim Biophys Acta. 2011;1811(10):597-606.
53. Soccio RE, Adams RM, Maxwell KN, Breslow JL. Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J Biol Chem. 2005;280(19):19410-8.
54. Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys. 2010;39:407-27.
55. Fridriksson EK, Shipkova PA, Sheets ED, Holowka D, Baird B, McLafferty FW. Quantitative analysis of phospholipids in functionally important membrane domains from RBL-2H3 mast cells using tandem high-resolution mass spectrometry. Biochemistry. 1999;38(25):8056-63.
56. Bose M, Whittal RM, Miller WL, Bose HS. Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and phosphate carrier protein. J Biol Chem. 2008;283(14):8837-45.
57. Yamada S, Yamaguchi T, Hosoda A, Iwawaki T, Kohno K. Regulation of human STARD4 gene expression under endoplasmic reticulum stress. Biochem Biophys Res Commun. 2006;343(4):1079-85.
58. Riegelhaupt JJ, Waase MP, Garbarino J, Cruz DE, Breslow JL. Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism. J Lipid Res. 2010;51(5):1134-43.
59. Rodriguez-Agudo D, Ren S, Hylemon PB, Redford K, Natarajan R, Del Castillo A, et al. Human StarD5, a cytosolic StAR-related lipid binding protein. J Lipid Res. 2005;46(8):1615-23.
60. Rodriguez-Agudo D, Ren S, Hylemon PB, Montanez R, Redford K, Natarajan R, et al. Localization of StarD5 cholesterol binding protein. J Lipid Res. 2006;47(6):1168-75.
61. Bose HS, Whittal RM, Ran Y, Bose M, Baker BY, Miller WL. StAR-like activity and molten globule behavior of StARD6, a male germ-line protein. Biochemistry. 2008;47(8):2277-88.
62. Chen YC, Meier RK, Zheng S, Khundmiri SJ, Tseng MT, Lederer ED, et al. Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules. Am J Physiol Renal Physiol. 2009;297(2):F380-8.
63. Letourneau D, Lorin A, Lefebvre A, Cabana J, Lavigne P, Lehoux JG. Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5. Biochim Biophys Acta. 2013;1831(11):1589-99.
64. Borthwick F, Allen AM, Taylor JM, Graham A. Overexpression of STARD3 in human monocyte/macrophages induces an anti-atherogenic lipid phenotype. Clin Sci. 2010;119(7):265-72.
65. Tsai YC, Weissman AM. The unfolded protein response, degradation from endoplasmic reticulum and cancer. Genes Cancer. 2010;1(7):764-78.
66. Golas A, Malek P, Piasecka M, Styrna J. Sperm mitochondria diaphorase activity-a gene mapping study of recombinant inbred strains of mice. Int J Dev Biol. 2010;54(4):667-73.
67. Alpy F, Stoeckel ME, Dierich A, Escola JM, Wendling C, Chenard MP, et al. The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein. J Biol Chem. 2001;276(6):4261-9.
68. Miller WL. StAR search-what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol. 2007;21(3):589-601.
69. Rone MB, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta. 2009;1791(7):646-58.
70. Hauet T, Yao ZX, Bose HS, Wall CT, Han Z, Li W, et al. Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol Endocrinol. 2005;19(2):540-54.
71. Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, et al. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics. 1995;28(3):367-76.
72. Alpy F, Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J Cell Sci. 2005;118(Pt 13):2791-801.
73. Strauss JF 3rd, Kishida T, Christenson LK, Fujimoto T, Hiroi H. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell Endocrinol. 2003;202(1-2):59-65.
74. Wang ML, Motamed M, Infante RE, Abi-Mosleh L, Kwon HJ, Brown MS, et al. Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes. Cell Metab. 2010;12(2):166-73.
75. Zhang M, Liu P, Dwyer NK, Christenson LK, Fujimoto T, Martinez F, et al. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J Biol Chem. 2002;277(36):33300-10.
76. Kishida T, Kostetskii I, Zhang Z, Martinez F, Liu P, Walkley SU, et al. Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J Biol Chem. 2004;279(18):19276-85.
77. Kanno K, Wu MK, Scapa EF, Roderick SL, Cohen DE. Structure and function of phosphatidylcholine transfer protein (PC-TP) /StarD2. Biochim Biophys Acta. 2007;1771(6):654-62.
78. Hanada K, Kumagai K, Tomishige N, Yamaji T. CERT-mediated trafficking of ceramide. Biochim Biophys Acta. 2009;1791(7):684-91.
79. Wirtz KW, Devaux PF, Bienvenue A. Phosphatidylcholine exchange protein catalyzes the net transfer of phosphatidylcholine to model membranes. Biochemistry. 1980;19(14):3395-9.
80. Johnson LW, Zilversmit DB. Catalytic properties of phospholipid exchange protein from bovine heart. Biochim Biophys Acta. 1975;375(2):165-75.
81. Wustner D, Mukherjee S, Maxfield FR, Muller P, Herrmann A. Vesicular and nonvesicular transport of phosphatidylcholine in polarized HepG2 cells. Traffic. 2001;2(4):277-96.
82. Durand S, Angeletti S, Genti-Raimondi S. GTT1/StarD7, a novel phosphatidylcholine transfer protein-like highly expressed in gestational trophoblastic tumour: cloning and characterization. Placenta. 2004;25(1):37-44.
83. Horibata Y, Sugimoto H. StarD7 mediates the intracellular trafficking of phosphatidylcholine to mitochondria. J Biol Chem. 2010;285(10):7358-65.
84. Olayioye MA, Hoffmann P, Pomorski T, Armes J, Simpson RJ, Kemp BE, et al. The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation. Cancer Res. 2004;64(10):3538-44.
85. Olayioye MA, Vehring S, Muller P, Herrmann A, Schiller J, Thiele C, et al. StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein. J Biol Chem. 2005;280(29):27436-42.
86. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003;426(6968):803-9.
87. van Meer G, Holthuis JC. Sphingolipid transport in eukaryotic cells. Biochim Biophys Acta. 2000;1486(1):145-70.